The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 17, 2018
Filed:
Jan. 19, 2017
Applicant:
Hope Medical Enterprises, Inc., Scottsdale, AZ (US);
Inventors:
Craig Sherman, Scottsdale, AZ (US);
Catherine Marie Smith, Grafton, WI (US);
Kevin Robert Wirtz, Belgium, WI (US);
Erich Schulze, Mission Viejo, CA (US);
Assignee:
Hope Medical Enterprises, Inc., Scottsdale, AZ (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 33/04 (2006.01); A61K 33/00 (2006.01); A61K 33/14 (2006.01); A61K 33/22 (2006.01); C01B 17/64 (2006.01); A61K 31/404 (2006.01); A61K 31/519 (2006.01); A61K 31/573 (2006.01); A61K 31/60 (2006.01); A61K 45/06 (2006.01); A61K 9/00 (2006.01); A61K 31/4418 (2006.01); A61K 31/727 (2006.01);
U.S. Cl.
CPC ...
C01B 17/64 (2013.01); A61K 9/0014 (2013.01); A61K 9/0019 (2013.01); A61K 31/404 (2013.01); A61K 31/4418 (2013.01); A61K 31/519 (2013.01); A61K 31/573 (2013.01); A61K 31/60 (2013.01); A61K 31/727 (2013.01); A61K 33/00 (2013.01); A61K 33/04 (2013.01); A61K 33/14 (2013.01); A61K 33/22 (2013.01); A61K 45/06 (2013.01); C01P 2006/80 (2013.01); Y10T 436/23 (2015.01);
Abstract
Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.